Mood stabilizers: Nursing pharmacology

Last updated: January 26, 2022

Mood stabilizers: Nursing pharmacology

Watch later

Watch later

Antibiotics - Glycopeptides: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Oxygen therapy: Nursing pharmacology
Blood products: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Analgesics: Nursing pharmacology
Antihistamines: Nursing pharmacology
Therapeutic communication: Nursing
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Immunoglobulins: Nursing pharmacology
Physiologic changes - Postpartum: Nursing
Assessment - Postpartum: Nursing
Cesarean birth: Nursing
Postpartum infections: Nursing
Assessment of gestational age: Nursing
Nutrition - Newborn: Nursing
Newborn adaptation to extrauterine life: Nursing
Hemolytic disease of the fetus and newborn: Nursing
Physical assessment - Neonate: Nursing
Group B streptococcus (GBS) infection in pregnancy: Nursing
Neonatal eye prophylaxis: Nursing pharmacology
Streptococcus agalactiae (Group B Strep)
Hyperbilirubinemia: Nursing process (ADPIE)
Large for gestational age (LGA) infant: Nursing
Hepatitis B virus (HBV) infection in pregnancy: Nursing
Brachial plexus injury: Nursing
Postpartum hemorrhage: Nursing
Psychosocial changes - Postpartum: Nursing
Oxytocin: Nursing pharmacology
Rho(D) immune globulin: Nursing pharmacology
Perinatal depression: Nursing
Shoulder dystocia: Nursing
Venous thromboembolism (VTE): Nursing process (ADPIE)
Shock - Hypovolemic: Nursing
Eye conditions: Inflammation, infections and trauma: Pathology review
Otitis media: Nursing
Ventricular septal defect
Disseminated intravascular coagulation (DIC): Nursing
Antepartum assessment - Fetus: Nursing
Common discomforts of pregnancy: Nursing
Ectopic pregnancy: Nursing
Fetal circulation: Nursing
Fetal development: Nursing
Gestational trophoblastic disease: Nursing
Hyperemesis gravidarum: Nursing
Multiple gestation: Nursing
Physiologic changes - Pregnancy: Nursing
Pregestational conditions: Nursing
Psychosocial changes - Pregnancy: Nursing
Spontaneous abortion: Nursing
Placenta previa: Nursing process (ADPIE)
Placental abruption: Nursing process (ADPIE)
Ergot alkaloids: Nursing pharmacology
Prostaglandins: Nursing pharmacology
Analgesics for obstetrics: Nursing pharmacology
Tocolytics: Nursing pharmacology
Prenatal care: Nursing
Preeclampsia and eclampsia: Nursing
Neonatal abstinence syndrome: Nursing
Sudden infant death syndrome (SIDS): Nursing
ADHD: Information for patients and families (The Primary School)
Stimulant medications for attention-deficit hyperactivity disorder (ADHD): Nursing pharmacology
Cerebral palsy: Nursing
Failure to thrive (FTT): Nursing
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Contraception - Barrier methods: Nursing
Syphilis: Nursing
Chlamydia trachomatis
Candidiasis: Nursing process (ADPIE)
Treponema pallidum (Syphilis)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Genital warts: Nursing
Contraception - Hormonal methods: Nursing
Dementia: Nursing
Alzheimer disease
Antiepileptics: Nursing pharmacology
Dyslipidemias: Pathology review
Schizophrenia: Nursing
Bipolar and related disorders
Mood stabilizers: Nursing pharmacology
Erectile dysfunction
Obsessive-compulsive disorder (OCD): Nursing
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Renal and urinary calculi: Nursing
Antipsychotics: Nursing pharmacology
Physical assessment - Mental status: Nursing
Delirium: Nursing
Restraints
Cataracts: Nursing
Glaucoma: Nursing process (ADPIE)
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Physical assessment - Peripheral vascular system: Nursing
Peripheral venous disease (PVD): Nursing process (ADPIE)
Amputation: Nursing
Treatment for Helicobacter pylori: Nursing pharmacology
Macular degeneration: Nursing
Eye conditions: Retinal disorders: Pathology review
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Anxiolytics and sedative-hypnotics: Nursing pharmacology
Thrombosis syndromes (hypercoagulability): Pathology review
Pulmonary embolism
Heart failure
Heart failure: Pathology review
Left-sided heart failure: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Nephrotic syndrome: Nursing
Immune response - Adaptive: Nursing
Inflammatory process: Nursing
Inflammation
Tuberculosis (TB): Nursing
Leukemia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Lung cancer: Nursing
Biology of cancer: Nursing
Skin cancer - Basal cell carcinoma, squamous cell carcinoma, and melanoma: Nursing
HIV (AIDS)
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type II: Nursing
Hypersensitivity reactions - Type IV: Nursing
Physical assessment - Neurological system: Nursing
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Stroke: Nursing process (ADPIE)
Shock - Septic: Nursing
Shock - Neurogenic: Nursing
Burn injury: Nursing
Thermoregulation : Nursing
Arrhythmias - Atrial flutter (Aflutter): Nursing
Arrhythmias - Atrial fibrillation (Afib): Nursing
Arrhythmias - Supraventricular tachycardia (SVT): Nursing
Arrhythmias - Ventricular tachycardia (Vtach): Nursing
Arrhythmias - Ventricular fibrillation (Vfib): Nursing
Arrhythmias - Premature atrial contractions (PACs): Nursing
Arrhythmias - Premature ventricular contractions (PVCs): Nursing
Arrhythmias - Asystole: Nursing
Arrhythmias - Sinus tachycardia and sinus bradycardia: Nursing
ECG rate and rhythm
Cardiomyopathy: Nursing
Shock - Cardiogenic: Nursing
Endocarditis: Nursing
Cardiac preload
Acute respiratory distress syndrome (ARDS): Nursing
Neonatal respiratory distress syndrome (NRDS): Nursing
Chronic kidney disease (CKD): Nursing
Acute kidney injury (AKI): Nursing process (ADPIE)
Dialysis care: Nursing
Aortic aneurysm: Nursing process (ADPIE)

Notes

MOOD STABILIZERS
DRUG NAME
lithium (Lithobid)
CLASS
Mood stabilizer; antimanic agent
MECHANISM OF ACTION
  • Inhibition of norepinephrine and dopamine release in the brain
  • Increase of serotonin production in the brain
  • Alteration of Na+/ K+ ion transport (brain, muscle cells)
INDICATIONS
Bipolar disorder
ROUTE(S) OF ADMINISTRATION
PO
SIDE EFFECTS
  • Nausea, vomiting, diarrhea
  • Muscle weakness, hyperreflexia, ataxia
  • Slurred speech
  • Seizures
  • Nephrogenic diabetes insipidus (polyuria, polydipsia)
  • Serotonin syndrome
CONTRAINDICATIONS AND CAUTIONS
  • Boxed warning: toxicity
  • Pregnancy, breastfeeding
  • Children < 12 years
  • Cardiac / renal / hepatic impairment
  • Schizophrenia, brain trauma, brain organ syndrome
  • NSAIDs, ACE inhibitors, diuretics
  • Dehydration, hyponatremia
  • Thyroid disease
NURSING CONSIDERATIONS
Assessment and monitoring
  • Mental status
  • Medication history
  • Baseline labs: BUN, creatinine, electrolytes, TSH, liver function, thyroid function, negative pregnancy test

Client education
  • Take as prescribed; do not crush or chew
  • Do not stop even if feeling better
  • Take with meals or milk
  • Regular monitoring of lithium levels required
  • Keep fluid and sodium balance consistent
  • Report signs or symptoms of toxicity
Author: Filip Vasiljević, MD
Author: Kaitlin Prey, RN
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Mood stabilizers are medications used to treat bipolar disorder, which is a mental health condition characterized by dramatic shifts in emotions, mood, and energy levels.

In other words, a person with bipolar disorder can alternate from extreme lows to extreme highs, so mood stabilizer medications can help smooth out these mood swings.

Now, the first-line mood stabilizer is lithium, but other medications can also be used, including antiepileptics, such as carbamazepine, valproic acid, and lamotrigine; and antipsychotics, like olanzapine.

Now, lithium is taken orally, and it’s rapidly absorbed by the gastrointestinal tract. Once absorbed, it travels to the brain and regulates the release of neurotransmitters through an unclear mechanism.

In particular, lithium seems to inhibit the release of norepinephrine and dopamine, while it increases the production of serotonin and alters the sodium-potassium ion transport in neurons, as well as in muscle cells.

It’s important to note that lithium has boxed warning for toxicity because it has a narrow therapeutic index, meaning that small variations in its blood concentrations can result in serious side effects and toxicity.

The most common causes of lithium toxicity include increased lithium dosage; decreased renal elimination, which is especially common in clients with kidney problems or hyponatremia; and the use of medications that can affect renal clearance, such as NSAIDs, ACE inhibitors, and diuretics.

Now the most important side effects of lithium toxicity include thirst, lethargy, slurred speech, and muscle weakness, as well as gastrointestinal side effects, such as nausea, vomiting, and diarrhea.

In addition, individuals may develop seizures, hyperreflexia or overactive reflexes, and ataxia, which refers to a lack of coordination and muscle control.

Another important side effect of lithium therapy is nephrogenic diabetes insipidus, which is characterized by polyuria or the production of large quantities of very dilute urine, as well as polydipsia or extreme thirst. Fortunately, this can be reversed by discontinuing lithium.

Finally, a potentially life-threatening effect of lithium therapy, especially when combined with certain antidepressant medications, is serotonin syndrome, which is caused by high levels of serotonin in the brain.

This typically presents with skin flushing, hyperthermia, agitation, muscle rigidity, seizures, and altered mental status or even coma.

Finally, lithium is contraindicated during pregnancy and breastfeeding, as well as in children under the age of 12. Also, this medication should not be used in clients with severe cardiac and renal impairment, since these conditions can cause variations in its blood concentrations and result in lithium toxicity.

Other important contraindications include hepatic impairment, schizophrenia, and brain trauma, as well as organic brain syndrome, which refers to all diseases of the brain that are manifested by psychiatric signs and symptoms.

Sources

  1. "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
  2. "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
  3. "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
  4. "Davis Advantage for Townsend’s Essentials of Psychiatric Mental-Health Nursing Concepts of Care in Evidence-Based Practice, Ninth edition" F.A. Davis Company (2022)
  5. "Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems" Int J Mol Sci (2021)
  6. "A taxonomy of clinical response to mood stabilizers" Bipolar Disord (2021)